Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease

 

 Buy Article Permissions and Reprints

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) is characterized by insulin resistance, which results in elevated serum concentration of free fatty acids (FFAs). Circulating FFAs provide the substrate for triacylglycerol formation in the liver, and may also be directly cytotoxic. Hepatocyte apoptosis is a key histologic feature of NAFLD, and correlates with progressive inflammation and fibrosis. The molecular pathways leading to hepatocyte apoptosis are not fully defined; however, recent studies suggest that FFA-induced apoptosis contributes to the pathogenesis of nonalcoholic steatohepatitis. FFAs directly engage the core apoptotic machinery by activating the proapoptotic protein Bax, in a c-jun N-terminal kinase-dependent manner. FFAs also activate the lysosomal pathway of cell death and regulate death receptor gene expression. The role of ER stress and oxidative stress in the pathogenesis of nonalcoholic steatohepatitis has also been described. Understanding the molecular mediators of liver injury should promote development of mechanism-based therapeutic interventions.

REFERENCES

• 1 Unger R H. Minireview: weapons of lean body mass destruction—the role of ectopic lipids in the metabolic syndrome.  Endocrinology. 2003;  144(12) 5159-5165
  CrossrefPubMedGoogle Scholar
• 2 Hotamisligil G S. Inflammation and metabolic disorders.  Nature. 2006;  444(7121) 860-867
  CrossrefPubMedGoogle Scholar
• 3 Gregor M F, Hotamisligil G S. Thematic review series: adipocyte biology. adipocyte stress: the endoplasmic reticulum and metabolic disease.  J Lipid Res. 2007;  48(9) 1905-1914
  CrossrefPubMedGoogle Scholar
• 4 Jaworski K, Sarkadi-Nagy E, Duncan R E, Ahmadian M, Sul H S. Regulation of triglyceride metabolism: IV. Hormonal regulation of lipolysis in adipose tissue.  Am J Physiol Gastrointest Liver Physiol. 2007;  293(1) G1-G4
  CrossrefPubMedGoogle Scholar
• 5 Baranova A, Gowder S J, Schlauch K et al.. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.  Obes Surg. 2006;  16(9) 1118-1125
  CrossrefPubMedGoogle Scholar
• 6 Chitturi S, Farrell G, Frost L et al.. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?.  Hepatology. 2002;  36(2) 403-409
  CrossrefPubMedGoogle Scholar
• 7 Hotamisligil G S, Arner P, Caro J F, Atkinson R L, Spiegelman B M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.  J Clin Invest. 1995;  95(5) 2409-2415
  CrossrefPubMedGoogle Scholar
• 8 Adams L A, Sanderson S, Lindor K D, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.  J Hepatol. 2005;  42(1) 132-138
  CrossrefPubMedGoogle Scholar
• 9 Kohjima M, Enjoji M, Higuchi N et al.. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.  Int J Mol Med. 2007;  20 351-358
  PubMedGoogle Scholar
• 10 Sanyal A J, Campbell-Sargent C, Mirshahi F et al.. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.  Gastroenterology. 2001;  120(5) 1183-1192
  CrossrefPubMedGoogle Scholar
• 11 Bakan E, Yildirim A, Kurtul N et al.. Effects of type 2 diabetes mellitus on plasma fatty acid composition and cholesterol content of erythrocyte and leukocyte membranes.  Acta Diabetol. 2006;  43(4) 109-113
  CrossrefPubMedGoogle Scholar
• 12 Puri P, Baillie R A, Wiest M M et al.. A lipidomic analysis of nonalcoholic fatty liver disease.  Hepatology. 2007;  46(4) 1081-1090
  CrossrefPubMedGoogle Scholar
• 13 Mari M, Fernandez-Checa J C. Sphingolipid signalling and liver diseases.  Liver Int. 2007;  27(4) 440-450
  CrossrefPubMedGoogle Scholar
• 14 Malhi H, Bronk S F, Werneburg N W, Gores G J. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis.  J Biol Chem. 2006;  281(17) 12093-12101
  CrossrefPubMedGoogle Scholar
• 15 Donnelly K L, Smith C I, Schwarzenberg S J et al.. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.  J Clin Invest. 2005;  115(5) 1343-1351
  PubMedGoogle Scholar
• 16 Nehra V, Angulo P, Buchman A L, Lindor K D. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis.  Dig Dis Sci. 2001;  46(11) 2347-2352
  PubMedGoogle Scholar
• 17 Bradbury M W. Lipid metabolism and liver inflammation: I. Hepatic fatty acid uptake—possible role in steatosis.  Am J Physiol Gastrointest Liver Physiol. 2006;  290(2) G194-G198
  CrossrefPubMedGoogle Scholar
• 18 Pohl J, Ring A, Hermann T, Stremmel W. Role of FATP in parenchymal cell fatty acid uptake.  Biochim Biophys Acta. 2004;  1686(1–2) 1-6
  PubMedGoogle Scholar
• 19 Pohl J, Ring A, Korkmaz U, Ehehalt R, Stremmel W. FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts.  Mol Biol Cell. 2005;  16(1) 24-31
  PubMedGoogle Scholar
• 20 Doege H, Baillie R A, Ortegon A M et al.. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis.  Gastroenterology. 2006;  130(4) 1245-1258
  CrossrefPubMedGoogle Scholar
• 21 Newberry E P, Xie Y, Kennedy S et al.. Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene.  J Biol Chem. 2003;  278(51) 51664-51672
  CrossrefPubMedGoogle Scholar
• 22 de Almeida I T, Cortez-Pinto H, Fidalgo G, Rodrigues D, Camilo M E. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis.  Clin Nutr. 2002;  21(3) 219-223
  CrossrefPubMedGoogle Scholar
• 23 Allard J P, Aghdassi E, Mohammed S et al.. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.  J Hepatol. 2008;  48(2) 300-307
  CrossrefPubMedGoogle Scholar
• 24 Wei Y, Wang D, Pagliassotti M J. Saturated fatty acid-mediated endoplasmic reticulum stress and apoptosis are augmented by trans-10, cis-12-conjugated linoleic acid in liver cells.  Mol Cell Biochem. 2007;  303(1–2) 105-113
  CrossrefPubMedGoogle Scholar
• 25 Listenberger L L, Han X, Lewis S E et al.. Triglyceride accumulation protects against fatty acid-induced lipotoxicity.  Proc Natl Acad Sci U S A. 2003;  100(6) 3077-3082
  CrossrefPubMedGoogle Scholar
• 26 Yamaguchi K, Yang L, McCall S et al.. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.  Hepatology. 2007;  45(6) 1366-1374
  CrossrefPubMedGoogle Scholar
• 27 Feldstein A E, Canbay A, Angulo P et al.. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.  Gastroenterology. 2003;  125(2) 437-443
  CrossrefPubMedGoogle Scholar
• 28 Susca M, Grassi A, Zauli D et al.. Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitis.  Dig Liver Dis. 2001;  33(9) 768-777
  CrossrefPubMedGoogle Scholar
• 29 Ribeiro P S, Cortez-Pinto H, Sola S et al.. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.  Am J Gastroenterol. 2004;  99(9) 1708-1717
  CrossrefPubMedGoogle Scholar
• 30 Malhi H, Gores G J, Lemasters J J. Apoptosis and necrosis in the liver: a tale of two deaths?.  Hepatology. 2006;  43(suppl 1) S31-S44
  CrossrefPubMedGoogle Scholar
• 31 Grassi A, Susca M, Ferri S et al.. Detection of the M30 neoepitope as a new tool to quantify liver apoptosis: timing and patterns of positivity on frozen and paraffin-embedded sections.  Am J Clin Pathol. 2004;  121(2) 211-219
  CrossrefPubMedGoogle Scholar
• 32 Wieckowska A, Zein N N, Yerian L M et al.. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.  Hepatology. 2006;  44(1) 27-33
  CrossrefPubMedGoogle Scholar
• 33 Green D R. Apoptotic pathways: ten minutes to dead.  Cell. 2005;  121(5) 671-674
  CrossrefPubMedGoogle Scholar
• 34 Green D R, Kroemer G. The pathophysiology of mitochondrial cell death.  Science. 2004;  305(5684) 626-629
  CrossrefPubMedGoogle Scholar
• 35 Wang D, Wei Y, Pagliassotti M J. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis.  Endocrinology. 2006;  147(2) 943-951
  CrossrefPubMedGoogle Scholar
• 36 Shimabukuro M, Zhou Y T, Levi M, Unger R H. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.  Proc Natl Acad Sci U S A. 1998;  95(5) 2498-2502
  CrossrefPubMedGoogle Scholar
• 37 Karaskov E, Scott C, Zhang L et al.. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis.  Endocrinology. 2006;  147(7) 3398-3407
  CrossrefPubMedGoogle Scholar
• 38 Kong J Y, Rabkin S W. Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A.  Biochim Biophys Acta. 2000;  1485(1) 45-55
  PubMedGoogle Scholar
• 39 Chai W, Liu Z. p38 mitogen-activated protein kinase mediates palmitate-induced apoptosis but not inhibitor of nuclear factor-kappaB degradation in human coronary artery endothelial cells.  Endocrinology. 2007;  148(4) 1622-1628
  PubMedGoogle Scholar
• 40 Miller T A, LeBrasseur N K, Cote G M et al.. Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes.  Biochem Biophys Res Commun. 2005;  336(1) 309-315
  CrossrefPubMedGoogle Scholar
• 41 Epand R F, Martinou J C, Montessuit S, Epand R M. Fatty acids enhance membrane permeabilization by pro-apoptotic Bax.  Biochem J. 2004;  377(Pt 2) 509-516
  CrossrefPubMedGoogle Scholar
• 42 Barreyro F J, Kobayashi S, Bronk S F et al.. Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis.  J Biol Chem. 2007;  282(37) 27141-27154
  CrossrefPubMedGoogle Scholar
• 43 Zhu Y, Schwarz S, Ahlemeyer B et al.. Oleic acid causes apoptosis and dephosphorylates Bad.  Neurochem Int. 2005;  46(2) 127-135
  CrossrefPubMedGoogle Scholar
• 44 Christen V, Treves S, Duong F H, Heim M H. Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A.  Hepatology. 2007;  46(2) 558-565
  CrossrefPubMedGoogle Scholar
• 45 Feldstein A E, Werneburg N W, Li Z, Bronk S F, Gores G J. Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.  Am J Physiol Gastrointest Liver Physiol. 2006;  290(6) G1339-G1346
  CrossrefPubMedGoogle Scholar
• 46 Feldstein A E, Werneburg N W, Canbay A et al.. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.  Hepatology. 2004;  40(1) 185-194
  CrossrefPubMedGoogle Scholar
• 47 Guicciardi M E, Leist M, Gores G J. Lysosomes in cell death.  Oncogene. 2004;  23(16) 2881-2890
  CrossrefPubMedGoogle Scholar
• 48 Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response.  Nat Rev Mol Cell Biol. 2007;  8(7) 519-529
  CrossrefPubMedGoogle Scholar
• 49 Ji C, Kaplowitz N. ER stress: can the liver cope?.  J Hepatol. 2006;  45(2) 321-333
  CrossrefPubMedGoogle Scholar
• 50 Ozcan U, Cao Q, Yilmaz E et al.. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes.  Science. 2004;  306(5695) 457-461
  CrossrefPubMedGoogle Scholar
• 51 Wei Y, Wang D, Topczewski F, Pagliassotti M J. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells.  Am J Physiol Endocrinol Metab. 2006;  291(2) E275-E281
  CrossrefPubMedGoogle Scholar
• 52 Puri P, Mirshahi F, Cheung O et al.. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease.  Gastroenterology. 2008;  134 568-576
  CrossrefPubMedGoogle Scholar
• 53 Johnson G L, Nakamura K. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease.  Biochim Biophys Acta. 2007;  1773(8) 1341-1348
  PubMedGoogle Scholar
• 54 Yamamoto K, Ichijo H, Korsmeyer S J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.  Mol Cell Biol. 1999;  19(12) 8469-8478
  PubMedGoogle Scholar
• 55 Kim B J, Ryu S W, Song B J. JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells.  J Biol Chem. 2006;  281(30) 21256-21265
  CrossrefPubMedGoogle Scholar
• 56 Hirosumi J, Tuncman G, Chang L et al.. A central role for JNK in obesity and insulin resistance.  Nature. 2002;  420(6913) 333-336
  CrossrefPubMedGoogle Scholar
• 57 Schattenberg J M, Singh R, Wang Y et al.. JNK1 but not JNK2 promotes the development of steatohepatitis in mice.  Hepatology. 2006;  43(1) 163-172
  CrossrefPubMedGoogle Scholar
• 58 Tuncman G, Hirosumi J, Solinas G et al.. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance.  Proc Natl Acad Sci U S A. 2006;  103(28) 10741-10746
  CrossrefPubMedGoogle Scholar
• 59 Weisberg S P, McCann D, Desai M et al.. Obesity is associated with macrophage accumulation in adipose tissue.  J Clin Invest. 2003;  112(12) 1796-1808
  CrossrefPubMedGoogle Scholar
• 60 Solomon S S, Usdan L S, Palazzolo M R. Mechanisms involved in tumor necrosis factor-alpha induction of insulin resistance and its reversal by thiazolidinedione(s).  Am J Med Sci. 2001;  322(2) 75-78
  CrossrefPubMedGoogle Scholar
• 61 Li Z, Yang S, Lin H et al.. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.  Hepatology. 2003;  37(2) 343-350
  CrossrefPubMedGoogle Scholar
• 62 Barbuio R, Milanski M, Bertolo M B, Saad M J, Velloso L A. Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet.  J Endocrinol. 2007;  194(3) 539-550
  CrossrefPubMedGoogle Scholar
• 63 Feldstein A E, Canbay A, Guicciardi M E et al.. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice.  J Hepatol. 2003;  39(6) 978-983
  CrossrefPubMedGoogle Scholar
• 64 Inoue Y, Asanuma T, Smith N et al.. Modulation of Fas-FasL related apoptosis by PBN in the early phases of choline deficient diet-mediated hepatocarcinogenesis in rats.  Free Radic Res. 2007;  41(9) 972-980
  CrossrefPubMedGoogle Scholar
• 65 Siebler J, Schuchmann M, Strand S et al.. Enhanced sensitivity to CD95-induced apoptosis in ob/ob mice.  Dig Dis Sci. 2007;  52(9) 2396-2402
  CrossrefPubMedGoogle Scholar
• 66 Malhi H, Barreyro F J, Isomoto H, Bronk S F, Gores G J. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity.  Gut. 2007;  56(8) 1124-1131
  CrossrefPubMedGoogle Scholar
• 67 Volkmann X, Fischer U, Bahr M J et al.. Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver.  Hepatology. 2007;  46(5) 1498-1508
  CrossrefPubMedGoogle Scholar
• 68 Summers S A. Ceramides in insulin resistance and lipotoxicity.  Prog Lipid Res. 2006;  45(1) 42-72
  CrossrefPubMedGoogle Scholar
• 69 Paumen M B, Ishida Y, Muramatsu M, Yamamoto M, Honjo T. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis.  J Biol Chem. 1997;  272(6) 3324-3329
  CrossrefPubMedGoogle Scholar
• 70 Tepper A D, Cock J G, de Vries E, Borst J, van Blitterswijk W J. CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition.  J Biol Chem. 1997;  272(39) 24308-24312
  CrossrefPubMedGoogle Scholar
• 71 Mari M, Caballero F, Colell A et al.. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis.  Cell Metab. 2006;  4(3) 185-198
  PubMedGoogle Scholar
• 72 Feng B, Yao P M, Li Y et al.. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages.  Nat Cell Biol. 2003;  5(9) 781-792
  CrossrefPubMedGoogle Scholar
• 73 Devries-Seimon T, Li Y, Yao P M et al.. Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor.  J Cell Biol. 2005;  171(1) 61-73
  CrossrefPubMedGoogle Scholar
• 74 Chalasani N, Deeg M A, Crabb D W. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.  Am J Gastroenterol. 2004;  99(8) 1497-1502
  CrossrefPubMedGoogle Scholar
• 75 Seki S, Kitada T, Sakaguchi H. Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases.  Hepatol Res. 2005;  33(2) 132-134
  CrossrefPubMedGoogle Scholar
• 76 Madan K, Bhardwaj P, Thareja S, Gupta S D, Saraya A. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).  J Clin Gastroenterol. 2006;  40(10) 930-935
  CrossrefPubMedGoogle Scholar
• 77 Yesilova Z, Yaman H, Oktenli C et al.. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease.  Am J Gastroenterol. 2005;  100(4) 850-855
  CrossrefPubMedGoogle Scholar
• 78 Bonnefont-Rousselot D, Ratziu V, Giral P et al.. Blood oxidative stress markers are unreliable markers of hepatic steatosis.  Aliment Pharmacol Ther. 2006;  23(1) 91-98
  CrossrefPubMedGoogle Scholar
• 79 Chalasani N, Gorski J C, Asghar M S et al.. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.  Hepatology. 2003;  37(3) 544-550
  CrossrefPubMedGoogle Scholar
• 80 Weltman M D, Farrell G C, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.  Hepatology. 1998;  27(1) 128-133
  CrossrefPubMedGoogle Scholar
• 81 Chtioui H, Semela D, Ledermann M, Zimmermann A, Dufour J F. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.  Liver Int. 2007;  27(6) 764-771
  CrossrefPubMedGoogle Scholar
• 82 Albano E, Mottaran E, Vidali M et al.. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.  Gut. 2005;  54(7) 987-993
  CrossrefPubMedGoogle Scholar
• 83 Lee J Y, Zhao L, Youn H S et al.. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1.  J Biol Chem. 2004;  279(17) 16971-16979
  CrossrefPubMedGoogle Scholar
• 84 Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha.  Arterioscler Thromb Vasc Biol. 2005;  25(10) 2062-2068
  CrossrefPubMedGoogle Scholar
• 85 Shi H, Kokoeva M V, Inouye K et al.. TLR4 links innate immunity and fatty acid-induced insulin resistance.  J Clin Invest. 2006;  116(11) 3015-3025
  CrossrefPubMedGoogle Scholar
• 86 Szabo G, Velayudham A, Romics Jr L, Mandrekar P. Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4.  Alcohol Clin Exp Res. 2005;  29(suppl) 140S-145S
  CrossrefPubMedGoogle Scholar

Gregory J GoresM.D. 

Professor of Medicine, Miles and Shirley Fiterman Center for Digestive Diseases

Mayo Clinic, 200 First Street SW, Rochester, MN 55905

Email: gores.gregory@mayo.edu